Загрузка...
Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use
Multiple sclerosis (MS) is a chronic progressive neurodegenerative demyelinating disease affecting the central nervous system. Glatiramer acetate (GA; Copaxone®) was the first disease-modifying treatment (DMT) for MS successfully tested in humans (1977) and was approved by the US Food and Drug Admin...
Сохранить в:
| Опубликовано в: : | Mult Scler Int |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6350531/ https://ncbi.nlm.nih.gov/pubmed/30775037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7151685 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|